As an investor who typically plans to hold stocks for the long term, I keep an active eye on patent filings and industry trends to help me get an idea as to whether the long term picture of an investment remains intact. Part of my main investment rationale for Antares Pharma has been that the future looks bright for the company, and that the market has completely discounted the pipeline from the valuation.